Long-acting injectable CAB vs. daily oral TDF/FTC for PrEP among MSM and TGW – Slides

Oral presentation by Raphael J. Landovitz at the HPTN Annual Meeting in May 2021. The presentation provided a rapid overview of the HPTN 083 study, the study describes the CAB as the first long-acting injectable agent to demonstrate robust HIV prevention efficacy. The result of this study shows that The PrEP regimen containing CAB-LA was superior to a daily oral regimen of TDF/FTC.

Preparing for long-acting injectable antiretroviral therapy for HIV in Los Angeles – Preliminary Findings Report

CHIPTS conducted a formative study to provide the groundwork to support successful implementation of LAI ART in Los Angeles County. The aims of this study were to strengthen and develop partnerships and build capacity in partners to support research on implementation of LAI ART as part of a strategy to optimize viral suppression in Los Angeles County; To assess the policy, systems, financial, operational and clinical level barriers to and facilitators of the rollout and scale-up of LAI ART in Los Angeles County; and to assess the end-user (consumer) perceived barriers to and facilitators of LAI ART use in Los Angeles County. This report summarizes the preliminary study findings and recommendations to inform efforts to prepare for implementation of LAI ART in Los Angeles County.

2019 Annual Commission Meeting – Slides

Slide presentations by commissioners of the LA County Commission on HIV that discuss new and current funding, proposals, efforts, frameworks, directions, and timelines aimed at Ending the HIV Epidemic. The commission meeting allows guests and the public into a space where people of all opinions and backgrounds are able to contribute. The meeting strives to be introspective and understand and clarify our assumptions, while appreciating the complex intersectionality of the lives we live.

AIDSMeds Drug Chart – Infographic

This infographic includes information about Antiretroviral options abound for both those who are HIV treatment naive and those who are experienced. This quick-reference chart compares available medication options, including dosing and dietary restrictions. To learn more about these medications, including possible side effects and drug interactions, log on to AIDSmeds.com